// App-Quantinova.ai

TCT-70 : Final 5 year results from the COMPARE II trial: comparison between the durable polymer coated everolimus-eluting Xience/Promus stent and the biodegradable polymer coated biolimus-eluting Nobori stent in all comer population

Researchers

Presenter

  • Pieter Smits

Principal Investigators

  • Sjoerd H Hofma

  • Mario Togni

  • Peter den Heijer

  • Antonio Serra

  • Ton Slagboom

  • Ramiro Trillo

  • Mariano Valdes

  • Jose Vazquez

  • Vassilis Voudris

Medical Centers

  • Virgen de la Arrixaca University Hospital. Murcia School of Medi, MURCIA, Spain

  • Hospital Clinico Universitario, Santiago De Compostela, Spain

  • Complejo Hospitalario Universitario de A Coruna, A Coruna, Spain

  • Amphia hospital, Breda, Netherlands

  • University of Freiburg Medical Center, Freiburg, Germany

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • Onassis Cardiac Surgery Center, Athens, Greece.

  • VUmc, Amsterdam, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

Locations

  • Spain

  • Switzerland

  • Greece

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved